White Papers

October 2011

From Operational Excellence to Strategic Partner: A Call to Action For Pharmaceutical Marketing Operations

Pharmaceutical Marketing Operations is in transition. As brand teams shrink and demands grow, particularly in such areas as Medical/Regulatory/Legal (M/R/L) Review and Speaker Management, pharmaceutical executives are increasingly turning to Marketing Operations for help. This White Paper focuses on how how Marketing Operations teams are evolving to provide more efficiencies and consistency within a more complex regulatory environment.

August 2011

When Budgets Loom: Five Steps To Finding Your Sales Operations “Efficient Frontier”

When companies seek “efficiencies,” it’s usually a euphemism for cuts. Viewed differently, the search for efficiencies can strengthen operations and give leaders an opportunity to demonstrate their value to the business. In this White Paper, TGaS Advisors provides fact-based information on how to enhance the “science” part while supporting the “art” of decision-making.

April 2011

The New Commercial Model: Reality or Rhetoric?

To discern fact from fiction in a marketplace full of pressures, opportunities and threats,TGaS Advisors undertook a landscape benchmark-a systematic look at the drivers of change, changes undertaken or planned and viewpoints about capabilities required for the future-of the industry’s commercial models.

January 2011

Re-inventing Training and Development as a Key Player in the New Commercial Environment

This White Paper speaks to aligning Training and Development with where the larger business is going and how department leadership can help drive the necessary changes.

September 2010

Drug Sampling: Key Issues and Best Practices

A new White Paper examines how the industry is adjusting to greater scrutiny of drug sampling. Industry practices in four areas are analyzed and best practices are identified to help companies meet regulatory requirements while satisfying marketing objectives.

July 2010

State of the Industry: Mobile Marketing - What Every Brand Should Know

A white paper exploring the dramatic rise in the use of custom applications (“apps”), and in browsing websites using a smartphone.

May 2010

The Five Things We Need to Do to Re-invent Commercial Operations

A manifesto for leading and prospering in the new world of Pharmaceutical Commercial Operations.

Februray 2010

TGaS Advisors Confidence Index: Best Prognosis in Three Years

This Confidence Index captures senior executives’ assessment of the future of the pharmaceutical industry and their own companies, given a three-year time horizon.

January 2010

Social Media: A Path Forward

A white paper on the recent social media discussions with the FDA. Sometimes, it seems pharma can’t win - either we are chastized for not embracing new technologies to help our customers, or we are lambasted for using new technologies but not adhering to old regulations.This white paper suggests a balanced path to avoid either.

September 2009

Future of Managed Markets 2009: Aligning Resources to Customers

Aligning resources to customers in Managed Markets means working to identify and secure the right level of resources; creating the right incentives and programs for customers; and applying these resources to customers in order to optimize business relationships. This article identifies the most urgent concerns being addressed by Managed Markets leaders in the industry.

April 2009

Changed Industry Perspective on Paid Search: Internet Marketing Benchmark

On April 2, the FDA (DDMAC) released Untitled letters to 14 companies around the practice of paid search listings which raises major issues for pharmaceutical marketing programs. TGaS Advisors polled their Internet Benchmark clients on how their medical/regulatory/legal teams are interpreting the letters, seen as de facto guidelines for cyberspace promotion.

April 2009

Prescription for Success: Re-imagining Sales and Managed Markets as a ‘Closed-Loop’ System

TGaS Advisors presents the need for a new interactive system that breaks down traditional Pharmaceutical Company silos and encourages communication in real time with constant updates. A handful of the solutions detailed within the article regarding how to create a Closed-Loop Managed Markets (CLMM) System.

January 2008

What’s New in eDetailing? Not Much—Improving Strategy & Metrics is the Key to More Significant Results

June 2007

Closed Loop Promotion: Powerful New Sales & Marketing Technology or the Latest Buzz Word?

Other Resources:

Information Sheets

Presentations

Data and Statistics